Viral hepatitis poses a threat to the health of persons living in the United States. While there are clinical similarities, it is important to understand the different etiologic agents and methods of transmission in order to understand the needs of infected individuals and caregivers. This article provides an overview of the hepatitis viruses most common in this country and the activities rec ommended to prevent transmission.
Get full access to this article
View all access options for this article.
References
1.
Berkow R, Fletcher A, eds. The Merck Manual. 16th ed. Rahway, NJ: Merck Research Laboratories ; 1992.
2.
Centers for Disease Control.Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR.1990;39(No.RR-2):1-26.
3.
Rosenblum L. , Mirkin I., Allen D, Safford S, Hadler S. A multifocal outbreak of hepatitis A traced to commercially distributed lettuce . Am J Public Health.1990;80:1075-1080.
4.
Centers for Disease Control.Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Committee (ACIP). MMWR.1991;40(No.RR-13):1-25.
5.
Centers for Disease Control.Public Health Service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR. 1991;40(No.RR-4):1-17.
6.
Occupational Safety and Health Administration.Occupational exposure to bloodborne pathogens. Federal Register.1991;56:64004-64182.
7.
Backinger C.An analysis of written bloodborne infection control policies of U.S. home health care agencies. Poster presented at Association for Practitioners in Infection Control, Inc. 20th Annual Educational Conference and International Meeting; May 23-28,1993; Orlando, Fla.
8.
Choo Q., Kuo G., Weiner A., Overby L, Bradley D, Houghton M. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science . 1989;244:359-362.
9.
Kuo G., Choo Q., Alter H., et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science.1989;244: 362-364.
10.
Everhart J. , Di Bisceglie A., Murray L., et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med.1990;112:544-545.
11.
Forseter G. , Wormser G., Adler S., Lebovics E., Calmann M., O'Brien T.Hepatitis C in the health care setting. II. Seroprevalence among hemodialysis staff and patients in suburban New York City. Am J Infect Control.1993;21:5-8.
